MOUNT SINAI HEALTH SYSTEM, INC. 4
4 · GeneDx Holdings Corp. · Filed Nov 4, 2024
Insider Transaction Report
Form 4
Transactions
- Sale
Class A Common Stock
2024-10-31$75.00/sh−865,800$64,935,000→ 2,866,833 total
Footnotes (1)
- [F1]Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. All share amounts presented in this report reflect the 33:1 reverse stock split of the Issuer's Class A common stock effective May 4, 2023.